{"id":"d06da6a6-32ea-425c-aacb-06407692219d","kind":"news","code":"d06da6a6-32ea-425c-aacb-06407692219d","name":"Helixon raises RMB 500 million in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"华深智药完成5亿人民币A轮融资","eventDate":"2022-06-22T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T22:00:24.213Z","englishUpdatedAt":"2026-10-16T01:39:38.750Z","reviewedAt":"2026-10-16T01:39:38.750Z","snapshotAt":"2026-10-16T01:38:14.029Z","sourceHash":"8bd18b896186f47c67a39df02152162a923d228cc1d804e2ec8e20b7e660adc5","companyId":"b534c89b-a8c5-4be1-a2df-38e1e462a1ac","foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"654349c6-fd2e-4500-a7b7-c3e545f34ede","kind":"institutions","code":"UB-I049","name":"Gaoling Venture Capital","nameBasis":"transliterated","summary":"A venture capital platform under Hillhouse focused on early- and growth-stage technology and healthcare enterprises.","description":"A venture capital platform under Hillhouse focused on early- and growth-stage technology and healthcare enterprises.","country":null,"category":null,"originalName":"高瓴创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:25.130Z","englishUpdatedAt":"2026-10-15T21:28:29.607Z","reviewedAt":"2026-10-15T21:28:29.607Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7fd6fdd8d780de44580b114359860fd3320ef434794ac79a06928f749329af57","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gaoling-venture-capital"},{"id":"a7331e6f-31b6-41e9-be3c-084ebe9d9fe7","kind":"institutions","code":"UB-I019","name":"Gaorong Capital","nameBasis":"transliterated","summary":"An emerging venture capital firm covering TMT, AI, and consumer investments, with notable investments including Pinduoduo, Huya, and Mogujie.","description":"An emerging venture capital firm covering TMT, AI, and consumer investments, with notable investments including Pinduoduo, Huya, and Mogujie.","country":null,"category":null,"originalName":"高榕资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.139Z","englishUpdatedAt":"2026-10-15T21:41:18.630Z","reviewedAt":"2026-10-15T21:41:18.630Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7fa0e7e315ae3d1e83bdb160363ee12e882a601a724f02ad3a4d9678209fabc7","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gaorong-capital"},{"id":"b534c89b-a8c5-4be1-a2df-38e1e462a1ac","kind":"companies","code":"UB-C3400","name":"Helixon","nameBasis":"source-english","summary":"Developer of innovative drugs using AI.","description":"Huashen Zhiyao is an AI innovative drug developer.","country":"China","category":null,"originalName":"华深智药","eventDate":null,"website":"https://www.helixon.com/","sourceUpdatedAt":"2026-10-03T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:25:38.066Z","reviewedAt":"2026-10-20T18:25:38.066Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"88bd9a59c11fcb9e665111c7baae02b9c28b227d58146c6a132b6b10234af456","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/huashenzhiyao"},{"id":"5a6ed451-45b5-4419-9783-d6519094282f","kind":"institutions","code":"UB-I4507","name":"Neumann Capital","nameBasis":"original-brand","summary":"Neumann Capital is a U.S. venture capital firm, specializing in equity investment in seed-stage technology startups.","description":"Neumann Capital is a U.S. venture capital firm, specializing in equity investment in seed-stage technology startups.","country":"United States","category":null,"originalName":"Neumann Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T09:00:17.316Z","englishUpdatedAt":"2026-10-20T18:26:56.302Z","reviewedAt":"2026-10-20T18:26:56.302Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"f331c43a5611872f29c769c49bb78ab204e44aa58c4aa67a212693773da14cf1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/neumann-capital"},{"id":"c9cc1dee-c997-4bed-9a06-566f7a93cdd7","kind":"institutions","code":"UB-I6384","name":"Qingzhi Capital","nameBasis":"transliterated","summary":"Qingzhi Capital is a domestic venture capital firm, focused on equity investment in startups.","description":"Qingzhi Capital is a domestic venture capital firm, focused on equity investment in startups.","country":null,"category":null,"originalName":"清智资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:32:22.608Z","englishUpdatedAt":"2026-10-15T18:21:17.293Z","reviewedAt":"2026-10-15T18:21:17.293Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"31a90dea1c1c246e3cc8503aa930b4bdb75f81d9d1364aa99411f54b972441db","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qingzhi-capital"},{"id":"ff7d41a5-b7cd-44a1-a23b-bc9e082639a4","kind":"institutions","code":"UB-I016","name":"Wuyuan Capital","nameBasis":"transliterated","summary":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","description":"A prominent venture capital firm, formerly Morningside Capital, covering technology, consumer businesses, and healthcare, with notable investments including XPeng, Kuaishou, and SenseTime.","country":null,"category":null,"originalName":"五源资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.242Z","englishUpdatedAt":"2026-10-15T21:43:23.741Z","reviewedAt":"2026-10-15T21:43:23.741Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7368ba44c3815996c52f9d8d28ae59336c59aa7539208a5ef5949f6cc0f793e0","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/wuyuan-capital"},{"id":"ce8590b0-eb3a-412e-bf41-0ab2fd0661b4","kind":"institutions","code":"UB-I724","name":"Xianghe Capital","nameBasis":"transliterated","summary":"An early- to growth-stage venture capital firm founded by Tang Hesong.","description":"An early- to growth-stage venture capital firm founded by Tang Hesong.","country":null,"category":null,"originalName":"襄禾资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:18.227Z","englishUpdatedAt":"2026-10-15T20:44:29.525Z","reviewedAt":"2026-10-15T20:44:29.525Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"cb1baf5b63c1addcfa0bac4bbcfbed76cfc7cef5679aacf9aba1828b5d2943ab","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/xianghe-capital"}],"path":"/news/d06da6a6-32ea-425c-aacb-06407692219d","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Helixon","path":"/companies/huashenzhiyao"}},"canonical":"https://uniquebase.ai/news/d06da6a6-32ea-425c-aacb-06407692219d"}